Menu
Search
|

Menu

Close
X

Akers Biosciences Inc AKER.OQ (NASDAQ Stock Exchange Capital Market)

0.40 USD
+0.01 (+1.47%)
As of Feb 16
chart
Previous Close 0.39
Open 0.40
Volume 631,609
3m Avg Volume 1,583,411
Today’s High 0.40
Today’s Low 0.38
52 Week High 2.85
52 Week Low 0.12
Shares Outstanding (mil) 59.17
Market Capitalization (mil) 23.66
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY17
3
FY16
3
FY15
2
EPS (USD)
FY17
-0.400
FY16
-0.609
FY15
-1.810
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
7.41
8.57
Price to Book (MRQ)
vs sector
0.90
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
0.00
15.12
LT Debt to Equity (MRQ)
vs sector
0.00
11.85
Return on Investment (TTM)
vs sector
-101.92
13.54
Return on Equity (TTM)
vs sector
-101.92
14.80

EXECUTIVE LEADERSHIP

Raymond Akers
Executive Chairman of the Board, Co-Founder, Secretary, Chief Scientific Director, Since 2017
Salary: $394,231.00
Bonus: --
John Gormally
Chief Executive Officer, Director, Since 2017
Salary: --
Bonus: --
John Cheneval
Executive Vice President, Sales and Marketing, Since 2015
Salary: --
Bonus: --
Gary Rauch
Senior Vice President - Finance, Treasurer, Since 2014
Salary: $78,414.00
Bonus: $2,500.00
Christopher Ellis
Vice President - Global Marketing, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

201 Grove Rd
WEST DEPTFORD   NJ   08086-2231

Phone: +1856.8488698

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

SPONSORED STORIES